The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


CONBRIZA



Pfizer Europe MA EEIGEU/1/09/511/1-4

Main Information

Trade NameCONBRIZA
Active SubstancesBazedoxifene
Dosage FormFilm-coated tablet
Licence HolderPfizer Europe MA EEIG
Licence NumberEU/1/09/511/1-4

Group Information

ATC CodeG03XC Selective estrogen receptor modulators
G03XC02 bazedoxifene

Status

License statusAuthorised
Licence Issued17/04/2009
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back